Ralph Schwall

Safety and antitumor activity of recombinant soluble Apo2 ligand

Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text

Apo2l Mrna, Medicinal Chemistry, Apo2l Treatment +13

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

Gail D. Lewis Phillips, Guangmin Li, Debra L. Dugger et al. · Cancer Research · 2008 · 1.6K citations

Drug Targeting, Breast Oncology, Disulfide Linkers +12

Vascular endothelial growth factor is essential for corpus luteum angiogenesis

N. Ferrara, Helen Chen, Terri Davis-Smyth et al. · Nature Medicine · 1998 · 629 citations

Developmental Biology, Angiogenesis, Endothelial Dysfunction +7

Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax

Heidi Leblanc, David A. Lawrence, Eugene Varfolomeev et al. · Nature Medicine · 2002 · 506 citations

Tumor-cell Resistance, Medicine, Apoptosis +8

Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer

Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha et al. · Cancer Research · 2006 · 477 citations

Pathology, Oncogenic Deletion, Cancer Biology +18